Imaging features of hepatic angiomyolipomas on real-time contrast-enhanced ultrasound
Authors:
- 1 May 2010
- journal article
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 83 (989) , 411-418
Abstract
The aim of this study was to evaluate the imaging features of hepatic angiomyolipoma (AML) on contrast-enhanced ultrasound (CEUS). The imaging features of 12 pathologically proven hepatic AML lesions in 10 patients who had undergone baseline ultrasound (BUS) and CEUS examinations were evaluated retrospectively. The enhancement extent, pattern and dynamic change, along with the enhancement process, on CEUS were analysed. The diagnostic results of BUS and CEUS before pathological examination were also recorded. The results showed that 75% (9/12) of the AML lesions exhibited mixed echogenicity on BUS and most showed remarkable hyperechogenicity in combination with a hypoechoic or anechoic portion. Arterial flow signals were detected in 75% (9/12) of the lesions on colour Doppler imaging. On CEUS, 66.7% (n = 8) of the 12 lesions exhibited hyperenhancement in the arterial phase, slight hyperenhancement (n = 2) or isoenhancement (n = 6) in the portal phase, and slight hyperenhancement (n = 1) or isoenhancement (n = 7) in the late phase. Three (25%) lesions exhibited hyperenhancement in the arterial phase and hypoenhancement in both portal and late phases. One (8.3%) lesion exhibited hypoenhancement throughout the CEUS process. Before pathological examination with BUS, only 3 (25%) lesions were correctly diagnosed as hepatic AML. Conversely, on CEUS, correct diagnoses were made for 66.8% (8/12) of hepatic AMLs. Therefore, arterial hyperenhancement and subsequent sustained enhancement on CEUS were found in the majority of hepatic AMLs. The combination of BUS and CEUS leads to the correct diagnosis in the majority of hepatic AMLs, and is higher than the success rate achieved by BUS alone.Keywords
This publication has 23 references indexed in Scilit:
- Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) - Update 2008Ultraschall in der Medizin - European Journal of Ultrasound, 2008
- Focal liver lesions: Role of contrast-enhanced ultrasoundEuropean Journal of Radiology, 2007
- Management of Hepatic AngiomyolipomaJournal of Gastrointestinal Surgery, 2007
- Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agentJournal of Clinical Ultrasound, 2006
- Hepatic angiomyolipoma: identification of an efferent vessel to be hepatic vein by contrast-enhanced harmonic ultrasoundBritish Journal of Radiology, 2005
- Guidelines for the Use of Contrast Agents in Ultrasound - January 2004Ultraschall in der Medizin - European Journal of Ultrasound, 2004
- Ultrasound Imaging with SonoVueAcademic Radiology, 2002
- Malignant angiomyolipoma of the liver: a hitherto unreported variantHistopathology, 2000
- Hepatic AngiomyolipomaAmerican Journal of Surgical Pathology, 1999
- Angiomyolipoma of the liver: A collective reviewJournal of Gastroenterology, 1994